Upgrading & Maximizing the Classics (Colchicine, Allopurinol, etc.)

Save

Upgrading & Maximizing the Classics (Colchicine, Allopurinol, etc.) examines how to optimize the use of time-tested gout therapies in today's increasingly complex patients.

Seronegative RA Disease Activity (7.17.202)

Save

Dr. Jack Cush reviews the news, journal articles and Gout features from this past week on RheumNow.com

What Lies Beneath - Uric Acid Deposition & Imaging

Save

This webinar explores the evolving role of imaging in the diagnosis and management of gout. Our expert panel will discuss when and how to use ultrasound, dual-energy CT (DECT), crystal identification, and conventional radiography, while addressing practical questions such as the role of imaging in diagnostic uncertainty, serial disease monitoring, and whether ultrasound is changing the need for synovial fluid analysis in everyday practice.

Gout QD clinics - lessons from the Clinic QD307-QD311

Save

QD307: Senior Year Gout https://youtu.be/_TGgcdQsfic QD308: Allopurinol for All Gout? Not Quite https://youtu.be/JAwUb-hqeFs QD309: Cellulitis Paradoxes https://youtu.be/j3feySk5wQo QD310: Gout: Is it the Journey or the Destination?

Gout Cavalcade (7.10.2026)

Save

Dr. Jack Cush reviews the news, journal articles and regulatory decisions from the past week. July is Gout: More than Flares month. Visit https://rheumnow.com/campaign/gout-campaign-july-2026 for all of our coverage throughout July.

Gout Journal Club

Save

Gout Journal Club will examine two influential publications: 1. "Treat-to-Target Urate-Lowering Treatment and Cardiovascular Outcomes in Patients with Gout" (Cipolletta et al., JAMA Internal Medicine, 2026) and 2. "Target Serum Urate Achievement and Chronic Kidney Disease Progression in Patients With Gout and Kidney Disease"(Wang et al., JAMA Internal Medicine, 2025).

Podcast Replay: Is it Time to Transition MOAs in RA?

Save

In August, Dr. Christina Charles-Schoeman and Dr. Manish Jain will return with a new episode exploring the latest clinical data on RA treatment after TNFi failure. Before that episode drops, revisit their 2025 conversation on disease control, real-world data, and guidelines that inform clinical decision-making after TNFi failure. Sponsored by AbbVie Medical Affairs + Health Impact.

ICYMI: Great Lectures; Great Presentations

Save

Dr. Jack Cush lectures on giving a great presentation; based on 40 years of lecturing in Rheumatology.

Generic Tofacitinib (6.26.2026)

Save

Dr. Jack Cush reviews the news and journal articles from RheumNow.com. Updates on tofacitinib, CAR-T therapy and AI.

DERM on RheumNow (June 2026)

Save

The Derm on RheumNow podcast is a collection of Citations and Content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, other CTD skin disorders. dermatology drugs, biiologics, JAKs - their use, efficacy and side effects. Features Dr. Jack Cush, Editor at RheumNow.com. Show Notes: - Breckenridge Pharmaceutical received FDA approval for their generic version of tofacitinib on 6/4/26.

Do You Zoster Vaccinate? (6.19.2026)

Save

Dr. Jack Cush reviews the news, journal reports and best ways to review EULAR 2026.

RheumNow EULAR 2026 Rheumatology Round Up

Save

Drs. Jack Cush & Arthur Kavanaugh, two of rheumatology’s most trusted voices, provide a breakdown of the latest breakthroughs and hottest topics in rheumatology from the EULAR 2026 meeting in London.